title: Immune Checkpoint Inhibition Is Effective in Hypermutant Glioblastoma.
abstract: bMMRD GBM has a higher neoantigen load than tumors that respond to immune checkpoint inhibitors.
mesh_terms: D059447:Cell Cycle Checkpoints; D005909:Glioblastoma / Q000276:immunology*; D006801:Humans